Meiyu Geng, PhD

Meiyu Geng, PhD

Chinese Academy of Sciences
Shanghai, China

Dr. Geng received her Ph.D. degree from Tokyo University, Japan. She is currently a professor and principle investigator of Shanghai Institute of Materia Medica, Chinese Academy of Sciences. She is also the Party Committee Secretary and Deputy Director of the institute. Dr. Geng’s research is focused on the discovery and development of molecularly targeted cancer therapies. She has led the development of over ten targeted therapies in the area of receptor tyrosine kinases and epigenetics, including five in clinical trial in China. In parallel to anticancer drug discovery, her team is engaged in biomarker discovery to guide personalized cancer therapy and mechanism-based combination therapy strategies. Dr. Geng has published more than 160 research articles in peer-review journals including Cancer Cell, Cell Res, J Natl Cancer Inst, Hepatology, Cancer Res etc.. She is the co-inventor of more than 70 domestic or international patents. Dr. Geng is the receipt of a number of prestigious national awards including “National Award for Technological Invention” etc..